COMMON STOCK PURCHASE WARRANT ALIMERA SCIENCES, INC.Alimera Sciences Inc • March 27th, 2023 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time upon or after the earlier of (i) immediately prior to a Change of Control and (ii) March 24, 2024 (the “Initial Exercise Date”) and on or prior to the earlier of (a) 5:00 p.m. (New York City time) on March 24, 2030 and (b) a Change in Control (the “Termination Date”) but not thereafter, to subscribe for and purchase from Alimera Sciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to reduction and adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 27th, 2023 • Alimera Sciences Inc • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of March 24, 2023, by and among Alimera Sciences, Inc., a Delaware corporation (the “Company”), and the purchasers set forth on Schedule 1 hereto (each, a “Purchaser”, and collectively, the “Purchasers”), and shall become effective as of the Closing Date (as defined below).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 27th, 2023 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
This Securities Purchase Agreement (as may be amended or restated, this “Agreement”) is dated as of March 24, 2023, between Alimera Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser”, and collectively, the “Purchasers”).
